These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 13909753)
21. Attenuated measles-virus vaccine studies in Israel. I. Comparison of reactions after inoculation of vaccine with gamma-globulin. LEVIN S; MOSES S; SHIMANSKY L; KRUGMAN S Am J Dis Child; 1962 Mar; 103():363-5. PubMed ID: 14464578 [No Abstract] [Full Text] [Related]
22. Exaggerated natural measles following attenuated virus immunization. St Geme JW; George BL; Bush BM Pediatrics; 1976 Jan; 57(1):148-9. PubMed ID: 1246490 [TBL] [Abstract][Full Text] [Related]
23. INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE. KIMURA M; ISHIGURO Y Jpn J Med Sci Biol; 1965 Feb; 18():65-71. PubMed ID: 14300296 [No Abstract] [Full Text] [Related]
24. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus. Willis MF; Warburton MF Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112 [No Abstract] [Full Text] [Related]
25. [On vaccination against measles with live and attenuated virus (Schwarz strain)]. Monaci V; Imperato C; Battistini A; Nardi G; Grzincich GL; Bellelli E; Mazzeo G Ann Sclavo; 1973; 15(3):134-40. PubMed ID: 4776383 [No Abstract] [Full Text] [Related]
28. Development of attenuated measles-virus vaccines. A summary of recentinvestigation. ENDERS JF; KATZ SL; HOLLOWAY A Am J Dis Child; 1962 Mar; 103():335-40. PubMed ID: 13890168 [No Abstract] [Full Text] [Related]
29. [Preliminary data on the preventive activity of inactivated measles vaccine]. LOZOVSKAIA LS; TITOVA AI; EGOROVA LP Pediatriia; 1962 Aug; 40():73-7. PubMed ID: 14467017 [No Abstract] [Full Text] [Related]
30. Studies on an attenuated measles-virus vaccine. IV. Administration of vaccine by several routes. Black FL; Sheridan SR N Engl J Med; 1960 Jul; 263():165-9. PubMed ID: 13801146 [No Abstract] [Full Text] [Related]
31. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines. Weibel RE; Buynak EB; Stokes J; Hilleman MR Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864 [No Abstract] [Full Text] [Related]
32. [CHANGES IN TUBERCULIN ALLERGY IN SUBJECTS HAVING BEEN VACCINATED AGAINST MEASLES BY ATTENUATED VACCINE]. YOSHIDA Y; YAMAMOTO H; KANEKO I; AKAMATSU H; KUMODE S Acta Paediatr Jpn; 1964 Dec; 26():19-25. PubMed ID: 14319123 [No Abstract] [Full Text] [Related]
34. [Seroepidemiology of measles in 1428 people from a copper mine of Chengde City]. Hao YW Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Oct; 6(5):289-91. PubMed ID: 3836746 [No Abstract] [Full Text] [Related]
35. Inactivated measles virus vaccine. II. Prevention of natural and experimental measles with the vaccine. FELDMAN HA; NOVACK A; WARREN J JAMA; 1962 Feb; 179():391-7. PubMed ID: 13892136 [No Abstract] [Full Text] [Related]
36. Clinical and immunologic observations on two lines of attenuated measles vaccine virus upon passage in chick embryo cell culture. Chun H; T'eh-chang H; Kuo-hua T; Shou-teh C; Wen-huan W; Chi-ming C; Yu-fen K; Chü-yeh Y; Lan H Chin Med J (Engl); 1975 Jul; 1(4):283-6. PubMed ID: 810334 [No Abstract] [Full Text] [Related]
37. Development of extremely attenuated live measles virus vaccine (CAM-EX). Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692 [No Abstract] [Full Text] [Related]
38. Inactivated measles virus vaccine. Subsequent challenge with attenuated live virus vaccine. KARELITZ S; BERLINER BC; ORANGE M; PENBHARKKUL S; RAMOS A; MUENBOON P JAMA; 1963 Jun; 184():673-9. PubMed ID: 13962482 [No Abstract] [Full Text] [Related]
39. [Measles virus and its live vaccine]. MATSUMOTO M Shonika; 1961 Nov; 2():815-23. PubMed ID: 14471288 [No Abstract] [Full Text] [Related]